[1]国际肝脏病信息小组.肝胆疾病的命名规范、诊断要点及预后[M].王宝恩,贾继东,译.北京:人民卫生出版社,1997:66.
[2]盛传伦,王宵伟.肝内胆汁淤积[J].中国社区医师,2003,19(6):89.
[3]TraunerM,Boyer JL. Bile sait transporters: molecular characterization,function,and regulation[J].physiol Rev,2003,83(2):633671.
[4]Meier PJ,Stieger B. Bile salt transporters[J].Annu Rev Physiol,2002,64:635661.
[5]StPierre MV,KullakUblick GA,Hagenbuch B,et al. Transport of bile acids in hepatic and nonhepatic tissues[J].J Exp Biol,2001,204(pt 10):16731686.
[6]Gerloff T,Stieger B,Hagenbuch B,et al. The sister of Pglycoprotein represents the canalicular bile salt export pump of mammalian liver[J].J Biol Chem,1998,273(16):1004610050.
[7]杨红莲,吴纯启,廖明阳.肝内胆汁淤积发生机制的研究进展[J].毒理学杂志,2007,21(1):6568.
[8]Arrese M,Ananthananarayanan M,Suchy FJ. Hepatobility transport:molecular mechanisms of development and cholestasis[J].Pediatr Res,1998,44(2):141147.
[9]王安红,刘路,周昆.胆汁淤积与胆汁酸转运蛋白关系的研究进展[J].医学综述,2013,19(1):1618.
[10]陆伦根,曾民德.胆汁酸对线粒体的毒性作用[J].肝脏,2008,13(4):343346.
[11]兰绍阳,佘世锋,张达坤.茵陈蒿汤对肝内胆汁淤积湿热证大鼠肝组织NTCP表达的影响[J].中药新药与临床药理,2012,23(3):279283.
[12]罗琳,吴锋,窦志华,等.芍药苷对胆汁淤积肝损伤保护作用机制研究[J].南通大学学报(医学版),2011,31(6):450452.
[13]周方,许红梅.大黄素对胆汁淤积大鼠肝细胞转运体基因表达的影响[J].第四军医大学学报,2009,30(22):26632666.
[14]周方,许红梅.大黄素对肝内胆汁淤积大鼠Pgp表达的影响[J].中国中药杂志,2007,35(7):908911.
[15]詹雪晶,蔡霈,刘秀芳,等.小叶黑柴胡茎叶总黄酮对ANIT所致肝内胆汁淤积大鼠的影响[J].中国药理学通报,2010,26(6):780782.
[16]Rosario J,Sutherland E,Zaccaro L,et al.Ethinylestradiol administration selectively alters liver sinusoidal membrane liqid fluidity and protein composition[J].Biochemistry,1988,27(11):39393946.
[17]Arrese M, Pizarro M,Solis N, et al. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradio induced cholestasis. Effects of ursodeoxycholic acid adminstration[J].Biochemical pharmacology,1995,50(8):12231232.
[18]贾玉红,贾玉杰,姜妙娜.雌激素性肝内胆汁淤积发病机制的研究进展[J].大连医科大学学报,2001,23(2):144146.
[19]程良斌,赵友云,汪晖,等.黛矾散对雌激素诱导的大鼠肝内胆汁淤积的影响[J].临床肝胆病杂志,2003,19(6):370371.
[20]Karpen SJ.Nuclear receptor regulation of hepatic function[J].Hepatology,2002,36(6): 832850.
[21]Kast HR,Goodwin B,Tarr PT,et al.Regulation of multidrug resistanceassociated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor,farnesoid Xactivated receptor,and constitutive androstane receptor[J].J Biol Chem,2002,277(4):29082915.
[22]Stedman CA,Liddle C,Coulter SA,et al.Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury[J].Proc Natl Acad Sci USA,2005,102(6):20632068.
[23]唐志鹏,刘平.茵栀黄通过激活核受体组成型雄烷受体促进胆红素的清除[J].国外医学(中医中药分册),2004,26(3):181182.
[24]夏延哲,韦炳华,陈杰,等.旱莲草单体对人孕烷X受体调控CYP3A4转录表达的调节作用[J].今日药学,2012,22(3):129133.
[25]关志男,李赞,王燕.青蒿素对孕烷X受体和组成型雄烷受体介导的CYP3A4和CYP2B6转录调节作用[C]//中国药理学会药物代谢专业委员会.第十届全国药物和化学异物代谢学术会议暨第三届国际ISSX/CSSX联合学术会议论文集,南京,2012:3637.
[26]赵春景,王芳,赫飞.赤芍对乙肝黄疸患者红细胞通透性的影响[J].中医药研究,1999,15(5):4243.
[27]罗琳,窦志华,吴锋,等.赤芍总苷退黄降酶的作用及机制研究[J].中国现代应用药学,2010,27(4):285288.
[28]赵营,张玉林,徐林刚,等.甘草酸、甘草次酸及苦参碱等对实验性胆汁淤积大鼠作用的比较[J].中国药科大学学报,2007,38(3):256260.
[29]Wagner M,Zollner G,Trauner M.New molecular insights into the mechanisms of cholestasis[J].J Hepatol,2009,51(3):565580.
[30]Kosters A,Karpen SJ.The role of inflammation in cholestasis:clinical and basic aspects[J].Semin Liver Dis,2010,30(2):186194.
[31]郭红梅,王建设.炎症在胆汁淤积中的作用[J].肝脏,2012,17(8):574576.
[32]董伟,梁爱华,李春英.龙胆泻肝丸对胆汁淤积大鼠肝脏多药耐药蛋白及中性粒细胞CD18表达影响的研究[J].中国实验方剂学杂志,2011,17(21):214217.
[33]郑婷婷,于芳芳,姚嘉明,等.大黄浸液对急性肝内胆汁淤积大鼠肝脏NFκB表达的影响[J].浙江中医杂志,2013,48(5):380381.
[34]蔡丹莉,陈芝芸,于芳芳,等.三黄柴术方对急性肝内胆汁淤积大鼠ICAM1、TNFa的影响[C]//中华中医药学会脾胃病分会.中华中医药学会脾胃病分会第二十四次全国脾胃病学术交流会论文汇编,昆明,2011:405406.
[35]王燕,陆伦根.氧化应激在胆汁淤积中的作用[J].肝脏,2012,17(7):501503.
[36]黄延风,朱朝敏.大黄对幼鼠肝内胆汁淤积的作用机制[J].第四军医大学学报,2006,27(13):11781181.
[37]周欣,黄志华,林汉华.大黄对急性肝内胆汁淤积大鼠治疗效应的实验研究[J].中国中西医结合杂志,2001,21(S1):7577.
[38]曹璐,李俊,黄成,等.栀子柏皮汤对α萘异硫氰酸酯诱导的肝内胆汁淤积大鼠的保护作用[J]. 安徽医科大学学报,2013,48(3):257261.
[39]程良斌,赵友云,汪晖,等.黛矾散对雌激素诱导的大鼠肝内胆汁淤积肝细胞膜流动性的影响[J]. 临床肝胆病杂志,2004,20(6):359360.
[40]刘萍,胡玉莲,黄志华.大黄对淤胆型大鼠胃肠消化间期MMC的影响及利胆机制探讨[J].华中医学杂志,2007,31(1):5355,57.
[1]陈玉超.中医药治疗晚期胃癌用药与剂型关系[J].环球中医药,2013,6(05):372.
[2]徐庆武 张志威.毛宇湘教授治疗艾滋病临床经验拾粹[J].环球中医药,2013,6(05):374.
[3]李海南 张艳娜 储利荣等.中医药大学开办日本分校的创新实践[J].环球中医药,2014,7(02):140.
[4]马英,姬航宇,甄仲,等.读《重剂起沉疴》小识[J].环球中医药,2013,6(01):44.
[5]莫爵飞,闫秀峰,倪青,等.芪蛭降糖胶囊治疗2型糖尿病早期下肢动脉硬化闭塞症104例[J].环球中医药,2013,6(02):105.
MO Jue fei,YAN Xiu feng,NI Qing..Clinical study on the effect of Qizhi Jiangtang Capsule(a TCM formula) in treating 104 patients with diabetic lower limbs arteriosclerosis obliterans(ASO)[J].,2013,6(03):105.
[6]王学谦,刘杰,林洪生,等.林洪生教授治疗肝内胆管癌术后验案浅析[J].环球中医药,2013,6(03):194.
[7]乐一萍,孙燕妮.中医防治慢性阻塞性肺疾病的机制研究进展[J].环球中医药,2013,6(03):226.
LE Yi ping,SUN Yan ni..The progress of Chinese medicine for prevention and treatment of chronic obstructive pulmonary disease mechanisms[J].,2013,6(03):226.
[8]刘敏,杨蓉,田晶辰,等.航天疾病的中医病机分析[J].环球中医药,2013,6(08):613.
[9]王丽晨,刘慧林,王麟鹏,等.下肢静脉曲张的中医药疗法研究近况[J].环球中医药,2013,6(08):635.
WANG Li chen,LIU Hui lin,WANG Lin peng..Research progress of the traditional Chinese medicine therapy on varicose veins[J].,2013,6(03):635.
[10]乔靖,林亮.中医药治疗支气管哮喘的研究概述[J].环球中医药,2013,6(10):769.
QIAO Jing,LIN Liang..Overview of research on traditional Chinese medicine treatment of bronchial asthma[J].,2013,6(03):769.